Famotidine (H2 Receptor Blocker)

Treatment for Gastritis and duodenitis

Typical Dosage: 20-40mg once or twice daily

Effectiveness
75%
Safety Score
78%
Clinical Trials
500
Participants
50K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
78
DangerousModerateSafe
Treatment Details
Dosage Range
20-40mg once or twice daily
Time to Effect
Hours for symptom relief, 6-12 weeks for healing
Treatment Duration
6-12 weeks, or longer for maintenance
Evidence Quality
HIGH
Number Needed to Treat (NNT)
6(Treat 6 patients to see 1 additional successful outcome)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$150
Monitoring:$50
Side Effect Mgmt:$10
Total Annual:$210
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$10,000/QALY
QALYs Gained
0.15
Outcome-Based Costs
Cost per Responder
$280
Cost per Remission
$323
Comparison vs Omeprazole (PPI)
Cost Difference
$-60/year
Less expensive
QALY Difference
-0.05 QALYs
Worse outcomes
Dominance
No dominance
Famotidine (H2 Receptor Blocker) Outcomes

for Gastritis and duodenitis

Efficacy Outcomes
Overall Effectiveness
+75%
Response Rate
+75%
Remission Rate
+65%
Common Side Effects
Headache
+3%
Dizziness
+2%
Diarrhea/Constipation
+2%

Sources:

nih.gov
nih.gov
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

FIX IT
Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov